AD Tx Revolution at ACAAI
Andrew F. Alexis, MD, MPH “We can all appreciate that there has truly been a revolution in the treatment of atopic dermatitis. [AD] Andrew F. Alexis, MD, MPH, asked attendees of the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting in Anaheim, California. “Inhibitors of the JAK/STAT pathway have been an… Read More »